Sandoz Tech Stack

Global generic and biosimilar manufacturer serving 900M patient treatments annually

Pharmaceutical Manufacturing Basel, BS 10,001+ employees Public Company

Sandoz operates a manufacturing-first organization with over 20,000 employees across 100+ nationalities, anchored in SAP infrastructure (ECC, S/4HANA, APO) for supply chain and operations. Current hiring acceleration is sales-led (70 roles) against a backdrop of regulatory intensity — pain points cluster around GMP/GDP compliance, export regulation adherence, and adverse event reporting, revealing the operational and legal complexity of multi-market pharma distribution. The active project roster (SBS continuous improvement, GXP training, tender acquisition) maps to execution priorities in operational discipline and market penetration.

Tech Stack 27 technologies

Core StackSAP Power Query Salesforce Siemens SAP S/4HANA Power BI Excel Microsoft Office DMAIC Outlook Microsoft Access Sanity PowerPoint Coursera CMMS Word HPLC GCP SAP ECC SAP APO Microsoft 365 Teams SharePoint OneDrive Concur QlikView

What Sandoz Is Building

◆Challenges

Gmp/gdp risk mitigation
Ensuring compliance with export regulations
Improving patient journey
Compliance with order management deadlines
Maximizing sales and market share
Managing litigation and compliance risks
Timely adverse event reporting
Improving financial processes
Acquiring tender positions
Working capital improvement

▲Active Projects

Educational events for clients
Multi-channel engagement plan implementation
Roll-out sbs continuous improvement methodology
Market intelligence gathering
Product launch support
Train the trainer capability building
Contract management
Develop opex and sbs capability building strategy
Gxp training program
Successful launches in key markets

Hiring Activity

Accelerating160 roles · 70 in 30d

Department

Sales

Manufacturing

Healthcare

Ops

Engineering

Finance

Product

Seniority

Mid

Senior

Junior

Manager

Intern

Lead

Director

C-Level

Notable leadership hires: Chief Accountant, Commercial Head, Head Legal & Compliance, SBS Lead, Medical Head

Company intelligence

Find more companies like Sandoz by tech stack, pain points and active projects

Get started free

About Sandoz

Sandoz manufactures generic and biosimilar medicines at scale, with a portfolio of approximately 1,300 products treating conditions from acute to oncologic. The company operates in 25+ countries with manufacturing, sales, and regulatory footprints, delivering 900 million patient treatments annually. As a public company headquartered in Basel, Switzerland, Sandoz traces pharmaceutical lineage to 1886 and holds milestone innovations including the world's first oral penicillin (1951) and first biosimilar (2006). The business model is capital- and compliance-intensive: active projects emphasize SBS continuous improvement methodology, GXP training program execution, and successful market launches in key territories, while pain points reflect the core operating constraints of pharma — tender acquisition, working capital management, regulatory timelines, and litigation/compliance risk.

HeadquartersBasel, BS

Company Size10,001+ employees

Hiring MarketsKazakhstan, Uzbekistan, United Kingdom, Russia, Japan, Turkey, Taiwan, India

Frequently Asked Questions

What is Sandoz's annual revenue?

Sandoz recorded net sales of USD 10.4 billion in 2024, derived primarily from a global portfolio of generic and biosimilar medicines.

What countries does Sandoz operate in?

Sandoz has active hiring in 25+ countries spanning Europe (UK, Switzerland, Austria, Poland, Greece, Denmark), Asia-Pacific (Japan, India, Thailand, Philippines, Vietnam, Taiwan), emerging markets (Kazakhstan, Uzbekistan, Russia, Belarus, Ukraine), and Americas (US, Brazil, Mexico).